Illumina Inc (ILMN)
Gross profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 2,745,000 | 2,743,000 | 2,776,000 | 2,811,000 | 2,971,000 | 3,116,000 | 3,169,000 | 3,204,000 | 3,153,000 | 2,966,000 | 2,722,000 | 2,348,000 | 2,203,000 | 2,235,000 | 2,357,000 | 2,502,000 | 2,467,000 | 2,395,000 | 2,344,000 | 2,346,000 |
Revenue (ttm) | US$ in thousands | 4,504,000 | 4,465,000 | 4,461,000 | 4,447,000 | 4,583,000 | 4,699,000 | 4,692,000 | 4,656,000 | 4,526,000 | 4,280,000 | 3,966,000 | 3,473,000 | 3,239,000 | 3,238,000 | 3,351,000 | 3,556,000 | 3,543,000 | 3,458,000 | 3,404,000 | 3,396,000 |
Gross profit margin | 60.95% | 61.43% | 62.23% | 63.21% | 64.83% | 66.31% | 67.54% | 68.81% | 69.66% | 69.30% | 68.63% | 67.61% | 68.01% | 69.02% | 70.34% | 70.36% | 69.63% | 69.26% | 68.86% | 69.08% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $2,745,000K ÷ $4,504,000K
= 60.95%
Illumina Inc's gross profit margin has been gradually decreasing over the last eight quarters, indicating potential challenges in maintaining profitability. The trend shows a consistent decline from 71.09% in Q1 2022 to 65.16% in Q4 2023. This drop may reflect factors such as increasing costs of goods sold or pricing pressures in the industry. Management should closely monitor and address these trends to sustain and improve the company's profitability in the future.
Peer comparison
Dec 31, 2023
Company name
Symbol
Gross profit margin
Illumina Inc
ILMN
60.95%
Avantor Inc
AVTR
33.71%
Bio-Rad Laboratories Inc
BIO
54.09%
Bruker Corporation
BRKR
51.05%
Cytek Biosciences Inc
CTKB
56.69%
Mettler-Toledo International Inc
MTD
59.16%
Revvity Inc.
RVTY
58.73%
Waters Corporation
WAT
59.20%